Angel Adegbesan
Stay informed with Angel Adegbesan’s coverage and analysis.

FinanceOne of the most shorted stocks on the market just leapt 99%, putting a ‘rib-crunching’ squeeze on bearish bettors
By Angel Adegbesan, Carmen Reinicke and BloombergMay 10, 2024

HealthWhy a biotech firm’s market value jumped from $3 million to $130 million in a day and is still way up from its ‘almost unfathomably low valuation’
By Angel Adegbesan and BloombergOctober 13, 2023

HealthWeight-loss drugs like Ozempic are in such huge demand that spending on them will hit $100 billion by 2035, analyst says
By Angel Adegbesan and BloombergSeptember 22, 2023
Most Popular




